Evidence map›Paper›PMID 38837058›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Cost-effectiveness of one-stop-shop [

Sietse van Mossel, Sopany Saing, Natasha Appelman-Dijkstra, Elske Quak, Abbey Schepers, Frits Smit, Lioe-Fee de Geus-Oei, Dennis Vriens

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. First-line [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. The Diagnostic Accuracy of [Diagnostics (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Challenges and unmet needs of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Review
  6. Cost-effectiveness of [¹¹C]Choline PET/CT as first-line imaging in primary hyperparathyroidism.European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. MR Pulse Sequences for Parathyroid Adenoma Imaging Using [Nuclear medicine and molecular imaging · 2026
    Article
  8. Is theLangenbeck's archives of surgery · 2025
    Observational
  9. Economic evaluation of [EJNMMI reports · 2025
    Article
  10. Article
  11. Article
  12. Conventional imaging techniques plusFrontiers in endocrinology · 2025
    Article
  13. Review
  14. [European journal of nuclear medicine and molecular imaging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sietse van MosselDepartment of Radiology, Section Nuclear Medicine, Leiden University Medical Centre, Leiden, The Netherlands. s.vanmossel-1@utwente.nl.ORCID 0000-0003-2313-0337
Sopany SaingFaculty of Behavioural Management and Social Sciences, Health Technology and Services Research, University of Twente, Enschede, The Netherlands.ORCID 0000-0001-5913-9654
Natasha Appelman-DijkstraDepartment of Internal Medicine, Division Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-5035-127X
Elske QuakDepartment of Nuclear Medicine, Centre François Baclesse, Caen, France.ORCID 0000-0003-0791-9899
Abbey SchepersDepartment of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Frits SmitDepartment of Radiology, Section Nuclear Medicine, Leiden University Medical Centre, Leiden, The Netherlands.
Lioe-Fee de Geus-OeiDepartment of Radiology, Section Nuclear Medicine, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0003-1817-2743
Dennis VriensDepartment of Radiology, Section Nuclear Medicine, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-5762-6766

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe conducted a cost-effectiveness analysis in which we compared a preoperative [

methodsWe developed a cohort-level state transition model to evaluate both imaging strategies respecting an intraoperative parathyroid hormone monitored treatment setting as well as a traditional treatment setting. The model reflects patients' hospital journeys after biochemically diagnosed primary hyperparathyroidism. A cycle length of twelve months and a lifetime horizon were used. We conducted probabilistic analyses simulating 50,000 cohorts to assess joint parameter uncertainty. The incremental net monetary benefit and cost for each quality-adjusted life year were estimated. Furthermore, threshold analyses regarding the tariff of [

resultsThe simulated long-term health effects and costs were similar for both imaging strategies. Accordingly, there was no incremental net monetary benefit and the one-stop-shop strategy did not result in lower costs. These results applied to both treatment settings. The threshold analysis indicated that a tariff of €885 for [

conclusionBoth preoperative imaging strategies can be used interchangeably. Daily clinical practice grounds such as available local resources and patient preferences should inform policy-making on whether a hospital should implement the one-stop-shop imaging strategy.

Indexed as

CholineCost-Benefit AnalysisHyperparathyroidism, PrimaryParathyroid NeoplasmsPositron Emission Tomography Computed TomographyAdenomaHumansCholinefluorocholineCost-effectivenessFluorocholineHyperparathyroidismParathyroidPET/CTSestamibi

Identifiers

PMID38837058
PMCPMC11457719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.